17 de julio de 2023
Margaret Faye Wilson, una líder en las industrias bancaria y minorista, falleció el 10 de julio. Se desempeñó como fideicomisaria en la Junta de Salk de 2010 a 2019 y fue una generosa donante del Instituto a lo largo de los años, incluyendo el apoyo al evento anual principal del Instituto, Symphony at Salk.

Prior to her service as a Salk Trustee, Wilson co-founded Wilson Boyles & Company, a business management and strategic planning consulting firm with offices in San Diego and Chicago. She previously held the position of senior vice president of the Risk Management Group for The Home Depot, also serving on that board of directors; and spent 21 years at Bank of America, where she was a top-level executive and manager, including executive vice president, and chairman and president of Security Pacific Financial Services (a wholly owned subsidiary of Bank of America Corporation).
Over the course of her career, Wilson served on multiple corporate boards, most recently Biocept, Inc. She also held positions on numerous civic boards in San Diego, including the San Diego Opera, The Civic Theater, the Museum of Contemporary Art San Diego, and the San Diego Humane Society.
Wilson is survived by her sister Paula Murphy, daughter Tara Wilson, granddaughter Ivey Wilson, and great grandchildren Eydie and Ernest Noble, as well as beloved dogs Chili and Ginger.
The Wilson family asks that donations in celebration of Wilson’s life be made to the Salk Institute, Helen Woodward Animal Center, or Los Angeles Opera.
Oficina de Comunicaciones
Tel.: (858) 453-4100
press@salk.edu
El Instituto Salk es un centro de investigación independiente y sin fines de lucro fundado en 1960 por Jonas Salk, creador de la primera vacuna segura y eficaz contra la poliomielitis. La misión del Instituto es impulsar una investigación fundamental, colaborativa y audaz que aborde los retos más acuciantes de la sociedad, entre ellos el cáncer, la enfermedad de Alzheimer y la vulnerabilidad agrícola. Esta ciencia fundamental sustenta todos los esfuerzos traslacionales, generando conocimientos que permiten el desarrollo de nuevos medicamentos e innovaciones en todo el mundo.